Cardinal Health (NYSE:CAH) missed the earnings target set by Wall Street analysts for its fiscal 2nd quarter, sending shares down slightly today.
The Dublin, Ohio, medical device and pharmaceutical company reported profits of $303 million, or 88¢ per share, on sales of $25.23 billion, for bottom-line growth of 15.6% despite a top-line slide of 6.8% compared with the same period in 2011.